Unusual Price MovementLilly's post-earnings rally continued on raised 2026 guidance and a fresh Wells Fargo target increase, with health-care peers also higher. ⓘ2 sources
Unusual Price MovementLilly's post-earnings rally continued on raised 2026 guidance and a fresh Wells Fargo target increase, with health-care peers also higher. ⓘSources:Lilly reports third-quarter 2026 financial results and raises full-year guidanceWells Fargo raised Eli Lilly's price target to $1,500 from $1,330 and maintained OverweightLilly reports third-quarter 2026 financial results and raises full-year guidanceWells Fargo raised Eli Lilly's price target to $1,500 from $1,330 and maintained Overweight+2 more+1 more